Activities All-en Hepatitis-en HepC-en

Meeting with Indonesian National Narcotics Agency

Peduli Hati Bangsa, together with the Clinton Health Access Initiative (CHAI) had the opportunity to have a discussion with the National Narcotics Agency (BNN). We were received by: In 2021 WHO reported that the number of HBV has reached 296 million and HCV around 58 million, with 23-39% of the total new HCV cases being…

All-en Hepatitis-en HepC-en public-health

Hepatitis Can’t Wait Don’t Just Be A Slogan

From the records of Peduli Hati Bangsa, delays in the procurement of Direct Acting Antiviral (DAA) drugs to treat Hepatitis C have occurred several times: And currently the Daclatasvir stock out occurs from the end of March to August 2023. For patients who have already started, it is certainly not easy because generic drugs are…

All-en Hepatitis-en HepC-en Hiv-en Reports-en

2021 Community based Monitoring Result

Report of the community led monitoring in 2021 as the our base for advocacy to improve HIV and Hepatitis C services this year. Access the report from this link: Thank you AmfAR, The Foundation for AIDS Research for the chance and precious learning process and we hope to push for a better quality of…

Activities All-en Hepatitis-en HepC-en Hiv-en News-en

Hepatitis C and HIV Screening in 2 Correctional Facilities – Bali

On Tuesday-Thursday, May 10-12 2022, screening for Hepatitis C (HCV) and HIV was carried out at the Class IIA Kerobokan Penitentiary (Lapas) and Class IIA Women’s Prison Denpasar (Bali) with a total of 1,326 inmates. The positivity rates for HCV were 2.94% and 2.49% for HIV. All those who are HCV positive will continue with…

Activities All-en Hepatitis-en HepC-en News-en

Meeting with Hepatitis Working Team, Indonesian Ministry of Health

Tuesday, 10 May 2022 Yayasan Peduli Hati Bangsa attended a meeting with Hepatitis Working Team of the Indonesian Ministry of Health to evaluate our 2021 work and to present the 2022 workplan, including some collaborative work with us. On this opportunity, we also discuss few challenges in the Hepatitis services that we recorded through last…